RecruitingNCT05662293

Characterization of Arrhythmia-induced Cardiomyopathy

Arrhythmia-induced Cardiomyopathy - a Prospective Observational Cohort Study

Sponsor

University Hospital, Basel, Switzerland

Enrollment

2,700 participants

Start Date

Jun 10, 2021

Study Type

OBSERVATIONAL

Conditions

Cardiomyopathy Arrhythmia-induced Cardiomyopathy (AiCM)

Summary

The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study investigates a condition called arrhythmia-induced cardiomyopathy (AiCM) — where an abnormal heart rhythm (arrhythmia) causes the heart muscle to weaken over time. Researchers are collecting data from patients to better understand how it develops and how it can be identified earlier. **You may be eligible if...** - You are 18 or older - You have been diagnosed with, or are suspected to have, AiCM (a heart condition caused by irregular heart rhythm) - You are willing to participate in the study and sign a consent form - (For the historical data component) You had a reduced heart pumping function alongside an arrhythmia diagnosis between 2010–2021 **You may NOT be eligible if...** - You are under 18 - You are currently experiencing an acute medical emergency (e.g., heart attack, severe trauma, sepsis, recent cardiac surgery, shock) - Your life expectancy is less than 1 year due to a terminal illness - You have refused participation in your hospital's general consent program Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERData collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part)

Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part). The assessment will be done via mail, letter or phone

OTHERData collection: Quality of Life (QoL) Questionnaire (prospective part)

Data collection: Quality of Life (QoL) Questionnaire (prospective part). The questionnaire "EQ-5D-5L questionnaire" will be used to assess quality of life.

OTHERData collection (retrospective study)

Anonymized search and review of patients electronic health records of the University Hospital of Basel for patients with a reduced LVEF and a concomitant (±1year or after any observation of a reduced LVEF in imaging) diagnosis of arrhythmia known to be causing AiCM.

OTHERData collection (prospective study database)

Data collection on alcohol consumption, family history, rhythm disorder, hospitalizations, cardiac assessments, adverse events at baseline, 6 months, 1 year, 2 years and 5 years.